Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
-
Axsome Therapeutics (AXSM) PT Raised to $186 at Ladenburg Thalmann, After Company Announces AXS-05 Drug Achieves Primary Endpoint in the ADVANCE-1 Pivotal Phase 2/3 Trial In Alzheimer’s Disease Agit
-
Axsome Therapeutics (AXSM) PT Raised to $165 at Ladenburg Thalmann
-
Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Axsome Therapeutics (AXSM) Prices 2M Share Offering at $87
-
Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock
-
Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock
-
Axsome Therapeutics (AXSM) PT Raised to $139 at Ladenburg Thalmann
-
Axsome Therapeutics (AXSM) PT Raised to $64 at Ladenburg Thalmann
-
Axsome Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
-
Axsome Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
-
Axsome Therapeutics (AXSM) PT Raised to $45 at Ladenburg Thalmann
-
UPDATE: Axsome Therapeutics (AXSM) PT Raised to $34 at Ladenburg Thalmann
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Axsome Therapeutics (AXSM) PT Raised to $31 at Ladenburg Thalmann
-
Axsome Therapeutics Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
-
Axsome Therapeutics (AXSM) Announces 3.74M Share Pricing at $3.74
-
Axsome Therapeutics Announces Pricing of Its Public Offering of Common Stock
-
Axsome Therapeutics (AXSM) Plans Public Offering of Common Stock
-
Axsome Therapeutics Announces Proposed Public Offering of Common Stock
-
Axsome Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference
-
Ladenburg Thalmann Starts Axsome Therapeutics (AXSM) at Buy
-
Axsome Therapeutics Announces Closing of Initial Public Offering
-
Axsome Therapeutics (AXSM) IPO Opens, Trades Flat
-
Axsome Therapeutics' (AXSM) IPO Prices at $9/Share
-
Axsome Therapeutics Announces Pricing of Initial Public Offering
-
Axsome Therapeutics Announces Pricing of Initial Public Offering

